6.
Lopez L, Selent J, Ortega R, Masaguer C, Dominguez E, Areias F
. Synthesis, 3D-QSAR, and structural modeling of benzolactam derivatives with binding affinity for the D(2) and D(3) receptors. ChemMedChem. 2010; 5(8):1300-17.
DOI: 10.1002/cmdc.201000101.
View
7.
He C, Han X, Zhang Y, Du Z, Si C, Wei B
. Sc(OTf)-catalyzed [3 + 2]-cycloaddition of nitrones with ynones. Org Biomol Chem. 2020; 19(2):457-466.
DOI: 10.1039/d0ob02158j.
View
8.
Steiger S, Li C, Backos D, Reigan P, Natale N
. Dimeric isoxazolyl-1,4-dihydropyridines have enhanced binding at the multi-drug resistance transporter. Bioorg Med Chem. 2017; 25(12):3223-3234.
PMC: 5813499.
DOI: 10.1016/j.bmc.2017.04.008.
View
9.
Zhan G, Zhou J, Liu R, Liu T, Guo G, Wang J
. Galanthamine, Plicamine, and Secoplicamine Alkaloids from Zephyranthes candida and Their Anti-acetylcholinesterase and Anti-inflammatory Activities. J Nat Prod. 2016; 79(4):760-6.
DOI: 10.1021/acs.jnatprod.5b00681.
View
10.
Nge C, Sim K, Lim S, Thomas N, Low Y, Kam T
. A Hexacyclic, Iboga-Derived Monoterpenoid Indole with a Contracted Tetrahydroazepine C-Ring and Incorporation of an Isoxazolidine Moiety, a Seco-Corynanthean, an Aspidosperma-Aspidosperma Bisindole with Anticancer Properties, and the Absolute.... J Nat Prod. 2016; 79(10):2709-2717.
DOI: 10.1021/acs.jnatprod.6b00674.
View
11.
Perrone M, Vitale P, Panella A, Ferorelli S, Contino M, Lavecchia A
. Isoxazole-Based-Scaffold Inhibitors Targeting Cyclooxygenases (COXs). ChemMedChem. 2016; 11(11):1172-87.
DOI: 10.1002/cmdc.201500439.
View
12.
Takahashi S, Kakinuma N, Uchida K, Hashimoto R, Yanagisawa T, Nakagawa A
. Pyridovericin and pyridomacrolidin: novel metabolites from entomopathogenic fungi, Beauveria bassiana. J Antibiot (Tokyo). 1998; 51(6):596-8.
DOI: 10.7164/antibiotics.51.596.
View
13.
Minami S, Tomita M, Takamatsu H, UYEO S
. The Schmidt reaction with some tetralone and indanone derivatives. Chem Pharm Bull (Tokyo). 1965; 13(9):1084-91.
DOI: 10.1248/cpb.13.1084.
View
14.
Tambara K, Pantos G
. Conversion of aldoximes into nitriles and amides under mild conditions. Org Biomol Chem. 2013; 11(15):2466-72.
DOI: 10.1039/c3ob27362h.
View
15.
Poulsen P, Vergura S, Monleon A, Jorgensen D, Anker Jorgensen K
. Controlling Asymmetric Remote and Cascade 1,3-Dipolar Cycloaddition Reactions by Organocatalysis. J Am Chem Soc. 2016; 138(20):6412-5.
DOI: 10.1021/jacs.6b03546.
View
16.
Berthet M, Cheviet T, Dujardin G, Parrot I, Martinez J
. Isoxazolidine: A Privileged Scaffold for Organic and Medicinal Chemistry. Chem Rev. 2016; 116(24):15235-15283.
DOI: 10.1021/acs.chemrev.6b00543.
View
17.
Humphries P, Benbow J, Bonin P, Boyer D, Doran S, Frisbie R
. Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonists. Bioorg Med Chem Lett. 2009; 19(9):2400-3.
DOI: 10.1016/j.bmcl.2009.03.082.
View
18.
Mukhopadhyay S, Batra S
. Direct Transformation of Arylamines to Aryl Halides via Sodium Nitrite and N-Halosuccinimide. Chemistry. 2018; 24(55):14622-14626.
DOI: 10.1002/chem.201803347.
View
19.
Ma L, Miao D, Lee J, Li T, Chen Y, Su G
. Synthesis and biological evaluation of heterocyclic ring-fused dammarane-type ginsenoside derivatives as potential anti-tumor agents. Bioorg Chem. 2021; 116:105365.
DOI: 10.1016/j.bioorg.2021.105365.
View
20.
Cantillo D, de Frutos O, Rincon J, Mateos C, Kappe C
. A scalable procedure for light-induced benzylic brominations in continuous flow. J Org Chem. 2013; 79(1):223-9.
DOI: 10.1021/jo402409k.
View